Corcept Therapeutics: Truist Securities raised the target price from $44 to $65.
Corcept Therapeutics公司： Truist Securities将目标价从44美元上调至65美元。
Corcept Therapeutics: Truist Securities raised the target price from $44 to $65.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated